General Information of Drug (ID: DM8VGRX)

Drug Name
RGX-202 Drug Info
Indication
Disease Entry ICD 11 Status REF
Gastrointestinal cancer 2C11 Phase 1 [1]
Cross-matching ID
PubChem CID
67701
TTD Drug ID
DM8VGRX

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Solute carrier family 6 member 8 (SLC6A8) TTYUHB5 SC6A8_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT03597581) A Study of RGX-202-01 as a Single Agent and as Combination Therapy in Patients With Advanced Gastrointestinal Malignancies. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Rgenix.